About Meditrina Cyprus Plc

Company Description

Meditrina Pharmaceuticals was founded in 2003 by a group of Pharmacists and experienced professionals in the pharmaceutical market.

In 2010 Meditrina Pharmaceuticals becomes part of Synapsis group of companies, a pharmaceutical group in Southern Eastern Europe with presence in Greece (Meditrina Pharmaceuticals Ltd), Cyprus (Synapsis Ltd), Romania (Solartium Group Srl), Bulgaria (Synapsis Bulgaria Ltd) and Moldova (Solartium Pharma Srl).

Meditrina Pharmaceuticals has offices in Athens and Thessaloniki and 31 employees. There are 4 sales units, covering every major area in the country, with 23 sales reps and 4 unit managers.

Year founded

2020

Served area

Cyprus + Greece

Headcount

31

Shareholder information

Shares outstanding

45,000,000

IPO

Sept. 29, 2021

Stock exchange(s)

Cyprus Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.